Quarterly ResultJul 22, 2026, 04:27 PM
Molina Healthcare Q2 EPS $1.19; Raises Full-Year 2026 Guidance to $5.25
AI Summary
Molina Healthcare reported its second quarter 2026 financial results, with GAAP diluted EPS of $1.19 and adjusted diluted EPS of $1.51, both significantly down year-over-year due to lower premium revenues and an increased Medical Care Ratio. Despite the Q2 declines, the company increased its full-year 2026 adjusted earnings guidance to at least $5.25 per diluted share, citing solid performance in Medicaid and Medicare segments and stabilized Medicaid rates. The company expects 2026 to be a trough year for Medicaid margins, with confidence for profitable growth in 2027.
Key Highlights
- Q2 2026 GAAP diluted EPS was $1.19, a 76% decrease year-over-year.
- Q2 2026 Adjusted diluted EPS was $1.51, a 74% decrease year-over-year.
- Q2 2026 Premium Revenue was $10.2 billion, a 6% decrease year-over-year.
- Full-year 2026 adjusted EPS guidance increased to at least $5.25 per diluted share.
- Full-year 2026 GAAP EPS guidance increased to at least $2.15 per diluted share.
- Consolidated Medical Care Ratio (MCR) for Q2 2026 was 92.2%.
- Operating cash flow for H1 2026 was $788 million, up from -$112 million in H1 2025.
- Total membership as of June 30, 2026, was approximately 4.9 million.
Price Impact
More from MOH